You are here:

Press Releases

Published on


Challenges of ending drug-resistant tuberculosis (DRTB) the focus of Special Edition of the International Journal of Tuberculosis and Lung Disease (IJTLD)

Published on

Drug-resistant TB (DRTB) continues to be a public health threat and is one of the leading antimicrobial resistant infections globally. Worldwide in 2019, close to half a million people developed DRTB. However, only 38 per cent of people with DRTB started treatments and of those treated, only 57 per cent were treated successfully.